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We report here the preliminary antimicrobial activity of substances produced by Bacillus subtilis NB-6 
(air flora isolate), Bacillus megaterium NB-3 (air flora isolate), Burkholderia mallei NB-8 (water isolate) 
and Corynebacterium kutscheri NB-1 (soil isolate) against a number of methicillin-resistant 
Staphylococcus aureus (MRSA). The MRSA were isolated from sheep, bovine, camel and poultry meat 
samples collected from retails shops and slaughter houses located in Amman area, Jordan. B. mallei 
NB-8 and C. kutscheri NB-1 were found to possess a good antimicrobial activity against MRSA strains. 
 






The spread of resistance to antibiotics undermines the 
therapeutic utility of anti-infective drugs in current clinical 
use (Bax et al., 2000). For example, Staphylococcus 
aureus, a major cause of community and hospital-
acquired infections, has developed resistance to most 
classes of antibiotics, and isolates exhibiting such 
resistance is drawing great concern. Methicillin-resistant 
S. aureus (MRSA) strains appeared in the hospital 
environment after introduction of the semisynthetic peni-
cillin, methicillin, leaving vancomycin as the last line of 
defense for MRSA treatment (Enright, 2003). With the 
appearance of vancomycin-resistant clinical isolates 
(Sieradzki et al., 1999), no antibiotic class is effective 
against multiresistant S. aureus infections. Thus, new 
antibiotic and therapy options are urgently needed to 
improve the management of bacterial infections 
(Saimann et al., 2001), and a major challenge is to find 
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 (MRSA). 
In this study, we report the discovery and preliminary 
antimicrobial activity of substances produced by Bacillus 
subtilis NB-6 (air flora isolate), Bacillus megaterium NB-3 
(air flora isolate), Burkholderia mallei NB-8 (water isolate) 
and Corynebacterium kutscheri NB-1 (soil isolate) against 
methicillin-resistant S. aureus (MRSA) isolated from meat 
samples in Amman area, Jordan. 
 
 
MATERIALS AND METHODS 
 
Strains and media 
 
Methicillin-resistant S. aureus strains (MRSA strain 1, 2, 3, 5, 6, 7, 8 
and 13) were isolated from meat samples from sheep, bovine, 
camel and poultry in Amman area, Jordan (Quddoumi et al., 2006). 
The MRSA strains were deposited in Jordan Culture Collection 
(JOCC). The antimicrobial substances-producing bacteria, B. sub-
tilis NB-6 (air flora isolate) (El-Banna, 2003), B. megaterium NB-3 
(air flora isolate) (El-Banna, 2003), B. mallei NB-8 (water isolate) 
(El-Banna, 2005a) and C. kutscheri NB-1 (soil isolate) (El-Banna, 
2005b), were isolated from different sources in Jordan and 
deposited in Jerash Culture Collection (JCC). MRSA strains were 
cultured at 37C on mannitol salt agar (Difco). The antimicrobial 
substances-producing bacteria were cultured at 27C on nutrient 
agar (Oxoid). 
  




Table 1. Antimicrobial activity of substances produced by Jordanian isolates (Corynebacterium kutscheri 
NB-1, Bacillus megaterium NB-3, Bacillus subtilis NB-6 and Burkholderia mallei NB-8) against methicillin-
resistant Staphylococcus aureus (MRSA). 
 
Antimicrobial activity of straina  
MRSA strains NB-1 NB-3 NB-6 NB-8 
MRSA 1 n.a.b n.a. n.a. w.a. 
MRSA 2 9.0 n.a. n.a. 9.0 
MRSA 3 n.a. n.a. n.a. 13.5 
MRSA 5 12.9 n.a. n.a. 14 
MRSA 6 n.a. n.a. n.a. n.a. 
MRSA 7 n.a. n.a. n.a. w.a. 
MRSA 8 8.5 n.a. n.a. w.a. 
MRSA 13 n.a. w.a.c n.a. 11 
 
aDiameter of inhibition zone (mm). 
bn.a.: No activity. 






Bacteria were transferred by loop from slants to 125 ml flasks 
containing 50 ml medium like that used in subsequent experimental 
cultures. All precultures were incubated at appropriate temperature 
on a rotary shaker (Sanyo Gallenhamp PLC, Leicester, LE 3 2uz, 




Agar diffusion test 
 
Extraction of the active substance from cells grown in liquid cultures 
(100 ml) was carried out as follows. Briefly, cells were pelleted by 
centrifugation and extracted with acetone, and the supernatant was 
extracted with ethylacetate. Both extracts were evaporated by a 
rotary evaporator (Heidolph instruments, GmbH and Co KG 
Vertrieb, Kelheim, Germany) at < 50C, and the dry substances 
(separately) were dissolved in 0.5 ml methanol. The antimicrobial 
activity of these extracts was carried against methicillin-resistant S. 
aureus strains (MRSA) by agar diffusion test. Filter discs containing 
10 µl of the active substance dissolved in methanol (acetone extract 
or ethylacetate extract) were placed on the test plates. The plates 
were incubated at 37C for 48 h, and the antimicrobial activity was 




Biotest plates preparation 
 
Cell suspension of 24 h MRSA precultures were prepared (O.D578 = 
1), and 0.5 ml of this suspension was used to inoculate 250 ml agar 
medium (20 ml per plate, Arab food and Media Applicances 
Company limited. Zarka industrial area, Jordan). 
 
 
RESULTS AND DISSCUSION 
 
The agar diffusion method was used to compare the 
antimicrobial activity of B. subtilis NB-6, B. megaterium 
NB-3, B. mallei NB-8 and C. kutscheri NB-1 against 
methicillin-resistant S. aureus (MRSA) isolated from meat 
samples from sheep, bovine, camel and poultry in 
Amman area, Jordan. As shown in Table 1, substances 
produced by B. mallei NB-8 showed good antimicrobial 
activity against MRSA 2, MRSA 3, MRSA 5 and MRSA 
13, and weak antimicrobial activity against MRSA 1, 
MRSA 7 and MRSA 8, while no antimicrobial activity 
against MRSA 6. MRSA 2, MRSA 5 and MRSA 8 were 
inhibited by substances produced by C. kutscheri NB-1. 
The other MRSA strains (MRSA 1, 3, 6, 7 and 13) were 
not inhibited at all. All MRSA strains were not inhibited by 
substances produced by B. subtilis NB-6 and B. 
megaterium NB-3 except MRSA strain 13 which was 
slightly inhibited by B. megaterium NB-3 produced 
substances. 
S. aureus is an important cause of a variety of diseases 
in human and animals worldwide (Gilot and Leeuwen, 
2004). Their ability to cause diseases in associated with 
several pathogenic factors including extracellular enzym-
es and toxins (Lee, 2003). Both animal and human 
isolates are generally resistant to penicillins (Seguin et 
al., 1999). Several reports suggest that the transfer of S. 
aureus between human and cattle is possible and that 
the infection of human by transmission through food 
products contaminated with animal MRSA is very 
plausible (Lee, 2003; Kaszanyitzky et al., 2003). Romero-
Tabarez et al. (2006) has previously reported an 
antimicrobial activity of substances produced by B. 
subtilis (soil isolate) against multidrug-resestant bacterial 
pathogen including methicillin-resistant S. aureus. 
In this study, we have described the antimicrobial acti-
vity of substances produced by bacteria against several 
methicillin-resistant S. aureus strains which may be pro-
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